| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |